Shenzhen Chipscreen Biosciences Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003LW0
CNY
31.30
-0.75 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
257.04
235.90
267.56
244.33
160.28
176.83
178.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
257.04
235.90
267.56
244.33
160.28
176.83
178.95
Raw Material Cost
36.50
37.84
38.23
36.80
29.63
33.78
29.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.54
8.76
9.42
7.63
9.88
8.63
8.96
Selling and Distribution Expenses
126.97
146.76
120.63
102.77
94.82
117.03
102.20
Other Expenses
4.31
4.74
4.44
4.18
3.98
5.41
3.32
Total Expenditure (Excl Depreciation)
215.09
240.76
212.66
188.97
174.15
213.59
173.73
Operating Profit (PBDIT) excl Other Income
41.900000000000006
-4.9
54.900000000000006
55.4
-13.899999999999999
-36.800000000000004
5.2
Other Income
3.65
5.43
6.20
7.66
10.12
92.64
3.98
Operating Profit (PBDIT)
42.42
15.79
76.03
78.50
14.35
-19.46
23.86
Interest
8.54
8.76
9.42
7.63
9.88
8.63
8.96
Exceptional Items
0.77
0.06
0.18
-0.05
0.05
0.02
-0.73
Gross Profit (PBDT)
220.54
198.06
229.33
207.53
130.65
143.05
149.61
Depreciation
0.00
18.35
18.35
18.10
18.10
16.87
16.87
Profit Before Tax
34.65
-11.26
48.44
52.72
-13.58
-44.94
-2.69
Tax
0.38
-0.45
1.07
-2.08
0.56
11.66
2.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.27
-19.81
41.18
48.75
-19.15
-63.49
-10.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.27
-19.81
41.18
48.75
-19.15
-63.49
-10.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
28.27
-19.81
41.18
48.75
-19.15
-63.49
-10.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,584.59
1,502.13
1,655.88
1,490.99
1,561.86
1,457.33
1,643.31
Earnings per share (EPS)
0.07
-0.05
0.1
0.12
-0.05
-0.16
-0.02
Diluted Earnings per share
0.07
-0.05
0.1
0.12
-0.05
-0.16
-0.02
Operating Profit Margin (Excl OI)
15.08%
-3.38%
19.24%
21.58%
-8.65%
-72.93%
1.69%
Gross Profit Margin
13.48%
3.0%
24.96%
28.98%
2.82%
-15.87%
7.92%
PAT Margin
11.0%
-8.4%
15.39%
19.95%
-11.95%
-35.9%
-5.63%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 60.32% vs 22.74% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 247.40% vs -4.92% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 823.81% vs 90.91% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -14.14% vs 19.28% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Shenzhen Chipscreen Biosciences Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
257.04
0
257.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
257.04
0
257.04
Raw Material Cost
36.50
0
36.50
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
8.54
0
8.54
Selling and Distribution Expenses
126.97
0
126.97
Other Expenses
4.31
0.00
4.31
Total Expenditure (Excl Depreciation)
215.09
0
215.09
Operating Profit (PBDIT) excl Other Income
41.95
0.00
41.95
Other Income
3.65
0
3.65
Operating Profit (PBDIT)
42.42
0
42.42
Interest
8.54
0
8.54
Exceptional Items
0.77
0
0.77
Gross Profit (PBDT)
220.54
0
220.54
Depreciation
0.00
0
0.00
Profit Before Tax
34.65
0
34.65
Tax
0.38
0
0.38
Provisions and contingencies
0
0
0.00
Profit After Tax
28.27
0
28.27
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.27
0
28.27
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
28.27
0
28.27
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,584.59
0
2,584.59
Earnings per share (EPS)
0.07
0
0.07
Diluted Earnings per share
0.07
0
0.07
Operating Profit Margin (Excl OI)
15.08%
0%
0.00
15.08%
Gross Profit Margin
13.48%
0%
0.00
13.48%
PAT Margin
11.00%
0%
0.00
11.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 25.70 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.94% vs -11.85% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 60.32% vs 22.74% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.83 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 242.93% vs -148.06% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 247.40% vs -4.92% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.88 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 273.08% vs -85.10% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 823.81% vs 90.91% in Mar 2025

Quarterly - Interest
Interest 0.85 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.41% vs -6.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -14.14% vs 19.28% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.08%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025